DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. (DMAC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
dmac · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$10.00
Consensus
$8.33
+49.8% upside
Low
$7.00
Median: $8 · Last Close: $5.56
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$8.33
49.8% upside
High Target
$10
79.9%
Low Target
$7
25.9%
Current Price
$5.56
as of today
Based on analyst price targets, the DMAC stock price prediction for the next 12 months ranges from $7 to $10. The consensus DMAC price forecast of $8.33 implies 49.8% upside from the current price of $5.56.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.35 | ↓ 3.74% |
1-day model range: $5.31–$5.39. Peak: $5.39 (-3.74%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -18.8% |
| 2028 | $4 | -27.2% |
| 2029 | $4 | -31.3% |
| 2030 | $4 | -33.4% |
| 2031 | — | -34.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DMAC · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-07-18 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-07-18 | Lake Street | Maintains | Buy→Buy |
| 2025-07-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-16 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-03-21 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on DiaMedica Therapeutics Inc. (DMAC) stock. Of the recent 21 rating actions, 1 were upgrades and 1 were downgrades. 6 analysts currently cover DMAC.
Analyst Recommendation Trends
DMAC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$54M
↑ 681.1% YoY
Revenue Next Year
$2M
↓ 95.9% YoY
EPS This Year
$-0.78
EPS Next Year
$-0.84
↑ 6.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast DMAC EPS of $-0.78 for the current fiscal year, based on estimates from 3 analysts. The DMAC revenue forecast is $54M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DMAC stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DMAC price target is $8.33 (+49.8% upside), with an analyst consensus of Buy.
The DMAC short-term stock prediction for tomorrow is $5.35 (-3.74%). The DMAC stock price prediction for 2027 estimates an average of $5. The DMAC stock prediction for 2030 projects a range of $3–$4.
DiaMedica Therapeutics Inc. trades on NASDAQ under the ticker DMAC. The DMAC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
DMAC forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month DMAC price target is $8.33, with a high forecast of $10.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +49.8% potential upside from the current price of $5.56.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.